WST

West Pharmaceutical Services
D

WST

Arincen83/100B

West Pharmaceutical Services total debt 1985–2026

West Pharmaceutical Services's total debt was 305.00M USD on 30 September 2026, up 2.5% on a year before. At the end of fiscal year 2025 it was 321.10M USD.

Last updated 9 Nov 2026 · Next report 11 Feb 2027

Total debt

Growth

Fiscal yearPeriod endingTotal debtGrowthCash and short-term investmentsNet cashDebt to equity
Latest quarter30 Sept 2026305.00M+2.49%464.10M159.10M0.10
FY202531 Dec 2025321.10M+5.18%791.30M470.20M0.10
FY202431 Dec 2024305.30M-1.20%484.60M179.30M0.11
FY202331 Dec 2023309.00M-2.80%853.90M544.90M0.11
FY202231 Dec 2022317.90M-2.27%894.30M576.40M0.12
FY202131 Dec 2021325.30M-0.12%762.60M437.30M0.14
FY202031 Dec 2020325.70M-1.09%615.50M289.80M0.18
FY201931 Dec 2019329.30M+67.92%439.10M109.80M0.21
FY201831 Dec 2018196.10M-0.46%337.40M141.30M0.14
FY201731 Dec 2017197.00M-13.82%235.90M38.90M0.15
FY201631 Dec 2016228.60M-23.34%203.00M-25.60M0.20
FY201531 Dec 2015298.20M-11.12%274.60M-23.60M0.29
FY201431 Dec 2014335.50M-10.17%255.30M-80.20M0.35
FY201331 Dec 2013373.50M-9.23%237.50M-136.00M0.41
FY201231 Dec 2012411.50M+17.77%174.30M-237.20M0.56
FY201131 Dec 2011349.40M-2.51%91.80M-257.60M0.53
FY201031 Dec 2010358.40M-5.58%110.20M-248.20M0.57
FY200931 Dec 2009379.60M-1.66%83.10M-296.50M0.66
FY200831 Dec 2008386.00M-2.30%91.50M-294.50M0.79
FY200731 Dec 2007395.10M+67.20%129.40M-265.70M0.81
FY200631 Dec 2006236.30M-15.91%47.10M-189.20M0.57
FY200531 Dec 2005281.00M+74.75%48.80M-232.20M0.84
FY200431 Dec 2004160.80M-8.11%68.80M-92.00M0.53
FY200331 Dec 2003175.00M0.00%37.80M-137.20M0.68
FY200231 Dec 2002175.00M-9.33%33.20M-141.80M0.87
FY200131 Dec 2001193.00M-3.21%42.10M-150.90M1.09
FY200031 Dec 2000199.40M+16.54%42.70M-156.70M0.97
FY199931 Dec 1999171.10M+21.26%45.30M-125.80M0.74
FY199831 Dec 1998141.10M+58.54%31.30M-109.80M0.61
FY199731 Dec 199789.00M-9.55%52.30M-36.70M0.32
FY199631 Dec 199698.40M-13.91%27.40M-71.00M0.39
FY199531 Dec 1995114.30M+97.75%17.40M-96.90M0.45
FY199431 Dec 199457.80M+78.95%27.20M-30.60M0.25
FY199331 Dec 199332.30M-23.28%5.20M-27.10M0.17
FY199231 Dec 199242.10M-27.91%3.00M-39.10M0.25
FY199131 Dec 199158.40M-25.61%2.70M-55.70M0.38
FY199031 Dec 199078.50M+35.11%2.20M-76.30M0.45
FY198931 Dec 198958.10M+5.44%1.60M-56.50M0.32
FY198831 Dec 198855.10M-8.93%5.10M-50.00M0.32
FY198731 Dec 198760.50M+36.57%12.70M-47.80M0.39
FY198631 Dec 198644.30M+45.72%7.40M-36.90M0.32
FY198531 Dec 198530.40M—8.50M-21.90M0.25

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Total debt counts commercial paper, term debt and lease liabilities.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet

Common questions about West Pharmaceutical Services's debt

Source: Financial Modeling Prep